INGN logo

INOGEN INC

INGNNASDAQ
πŸ† #3029 by market capEarnings Nov 3 Β· PostUS Equity
$999.10β–² $55.85 (+5.59%)
Simulated price
1hβ€”
24hβ–² 5.6%
7dβ–² 15153.4%
14dβ–² 15426.0%
30dβ–² 15200.2%
1yβ–² 13063.4%
🏦Market Cap
$157M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+3.4%
Slowing
πŸ“ŠGross Margin
44.3%
Healthy
πŸ’΅FCF Margin
0.2%
Thin
βš–οΈP/S Ratio
0.5x
Cheap
Otter Score
63
Fair

Trading Snapshot

Day Range
$989.21 – $1,007.70
52-Week Range
$5.34 – $9.13
Volume
$3.84B
Avg Volume
$2.68B
Shares Outstanding
27.1M
Next Earnings
Sep 13, 2026

Fundamentals Snapshot

Annual Revenue
$349M
Last Q Revenue
$95M
P/E Ratio
β€”
P/S Ratio
0.5x
EPS (TTM)
$-0.92
Dividend Yield
β€”

Why Investors Own INGN

  • βœ“High-growth profile β€” revenue up +25.5% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 73% gross margin and 6% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$349Mβ–² +23.1% YoY
Gross Margin (TTM)
72.7%β–² +4.1% YoY
Operating Income (TTM)
$40Mβ–² +23.1% YoY
Free Cash Flow (TTM)
$20Mβ–² +23.1% YoY

About INOGEN INC

Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
63/100

Analyst Price Target

β“˜
Average Target
$1,160.60
β–² +16.2% Upside
High Target$1,401.57
Low Target$1,079.99
Based on 13 analysts

Latest News & Updates